Patients with suspected COPD, based on symptoms of chronic cough, sputum production or dyspnoea should have a spirometry, preferably with bronchodilator testing to determine persistent airflow limitation. The definition of persistent airflow limitation requires that the ratio of the forced expiratory volume in one second (FEV1) to the forced vital capacity (FVC) be less than …
In the absence of specific guidelines on management of COPD in HIV patients, clinicians should follow the management guidelines proposed for the general population. Management of COPD is driven by symptoms and history of exacerbations, rather than the severity of airflow limitation or FEV1% predicted (31). There are a number of symptom assessment tools available …
Sarcoidosis is a multisystem granulomatous disorder characterized pathologically by the presence of noncaseating granulomas in involved organs (41). The disease is characterised by bilateral hilar adenopathy, pulmonary infiltrates and possible involvement of the skin, joints, or eyes. The diagnosis of sarcoidosis is established based on compatible clinical and radiologic findings supported by histologic evidence in …
1. Interstitial lung disease (ILD) Interstitial lung diseases such as NSIP and LIP are related to immune dysregulation and are now seen much less frequently due to the use of ART (50). Lymphocytic Interstitial Pneumonitis (LIP) This has been described predominantly in children with low CD4 T -cell counts and is characterised by bilateral reticulonodular …
Crothers K, Thompson BW, Burkhardt K, Morris A, Flores SC, Diaz PT, et al. HIV-associated lung infections and complications in the era of combination antiretroviral therapy. Proc Am Thorac Soc. 2011;8(3):275-81. Chinen J, Shearer WT. Molecular virology and immunology of HIV infection. J Allergy Clin Immunol. 2002;110(2):189-98. Cribbs SK, Crothers K, Morris A. Pathogenesis of …
Bruce J. Brew Immunology/HIV/Infectious Diseases Clinical Services Unit and Department of Neurology, St Vincent’s Hospital, Sydney NSW Zachary J. Webb-Harvey Immunology/HIV/Infectious Diseases Clinical Services Unit, St Vincent’s Hospital, Sydney NSW When evaluating neurological presentations in context of HIV (Human immunodeficiency virus) the differential diagnosis is determined by the stage of HIV infection, previous treatment history, …
Bruce J. Brew Immunology/HIV/Infectious Diseases Clinical Services Unit and Department of Neurology, St Vincent’s Hospital, Sydney NSW Zachary J. Webb-Harvey Immunology/HIV/Infectious Diseases Clinical Services Unit, St Vincent’s Hospital, Sydney NSW Neurological complications of HIV (Human immunodeficiency virus) continue to commonly impact people living with HIV (PLWH) in the post combined antiretroviral therapy (cART) era. The …
HIV associated neurocognitive disorder HIV associated neurocognitive disorder (HAND) represents a significant burden upon PLWH in the post cART era. In a metanalysis of 35,513 PLWH, HAND is reported at a prevalence of 42.6% (1), though it is less common in those with sustained viral suppression and early institution of cART. HAND adversely impacts PWLH …
Since the advent of cART CNS opportunistic infections have significantly declined, however they continue to cause significant morbidity and mortality in PLWH especially in those unaware of their HIV status (54). A recent multicentre retrospective analysis of patients presenting with encephalitis demonstrated a one-year mortality of 31.3% in PLWH compared to 16.0% in HIV negative …
Culture of the fungal skin or nail scraping may be required if the speciation of the fungus is required for directed antifungal treatment. Erroneous treatment with topical steroids may reduce available scale for scraping (tinea incognito) and biopsy for tissue culture may be required.
Developing a sustainable HIV, Viral Hepatitis and Sexual Health Workforce
Acknowledgement of Country
We pay our respects to the Aboriginal and Torres Strait Islander peoples of the past, present, and future, including the Gadigal peoples (Sydney office), the Turrbal and Jagera/Yuggera peoples (Brisbane office), and all First Nations people of the nations where we live and work.
ASHM Health | ABN 48 264 545 457 | CFN 17788 | Copyright © 2024 ASHM